Low-Intensity Chemotherapy, Ponatinib and Blinatumomab in Treating Patients With Philadelphia Chromosome-Positive and/or BCR-ABL Positive Acute Lymphoblastic Leukemia
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
University of Michigan Rogel Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Roswell Park Cancer Institute
University of Illinois at Chicago
City of Hope Medical Center
City of Hope Medical Center
M.D. Anderson Cancer Center
University of Nebraska
M.D. Anderson Cancer Center
University of Nebraska
Roswell Park Cancer Institute
Case Comprehensive Cancer Center
Case Comprehensive Cancer Center
M.D. Anderson Cancer Center
Masonic Cancer Center, University of Minnesota
Roswell Park Cancer Institute
University of Maryland, Baltimore
University of Maryland, Baltimore
University of Maryland, Baltimore
Nohla Therapeutics, Inc.
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
OHSU Knight Cancer Institute
Barbara Ann Karmanos Cancer Institute
Massachusetts General Hospital
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
University of Rochester
Barbara Ann Karmanos Cancer Institute
Memorial Sloan Kettering Cancer Center
Fred Hutchinson Cancer Center
Abramson Cancer Center at Penn Medicine
Mesoblast, Ltd.
City of Hope Medical Center
Vanderbilt-Ingram Cancer Center
University of Chicago
National Cancer Institute (NCI)
Northside Hospital, Inc.
Northside Hospital, Inc.
Case Comprehensive Cancer Center
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
Roswell Park Cancer Institute